drugset / Trial / NCT04619602
Inhaled Treatment for Bronchopulmonary Dysplasia
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to provide expanded access of S-nitrosylation therapy for the treatment of bronchopulmonary dysplasia
Timeline
- Start
- 2025-08-01
- Primary completion
- 2025-09-01
- Completion
- 2025-09-01
Outcome
Outcome not reported
Stopped: “FDA hold”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSNO | Unknown | 0.25 unknown | Inhaled |
| Subject | GSNO | Unknown | 0.5 unknown | Inhaled |
| Subject | GSNO | Unknown | 1 unknown | Inhaled |